India to United States: Plasma Export Trade Route

The India to United States Plasma corridor is one of India's established pharmaceutical export routes, with 768 shipments documented worth a combined $88.7K USD. The route is dominated by YASHRAJ BIOTECHNOLOGY LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's plasma manufacturing sector.

Across 92 active suppliers, the average shipment value stands at $115 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with plasma's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 33.0%, placing it at rank #14 among India's top plasma export destinations globally.

On the import side, key buyers of Indian plasma in United States include KEYSTONE BIOLOGICALS, IPROCESS GLOBAL RESEARCH INC., THE PURCHASE DEPARTMENT and 223 others. KEYSTONE BIOLOGICALS is the single largest importer with 4 shipments valued at $22.7K USD.

India's plasma exports to United States are driven primarily by a handful of large-scale manufacturers. YASHRAJ BIOTECHNOLOGY LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 92 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — YASHRAJ BIOTECHNOLOGY LIMITED, IPROCESS CLINICAL MARKETING PRIVATE LIMITED, INDO RIV CLINICAL PRIVATE LIMITED — together account for 58% of total trade value on this route. The average shipment value of $115 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as hbsag postive plasma - lot # kb156157 (1080 ml=nos) and consists of 2ml of human anti-hbs plasmain 2ml of a vial - 130 tubes, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KEYSTONE BIOLOGICALS is the largest importer with 4 shipments worth $22.7K USD — representing 26% of all plasma imports from India on this route. A total of 226 buyers are active on this corridor.